Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | +0.14% | +29.68% |
2023 | Nestle Reportedly May Sell Peanut Allergy Therapy to Stallergenes | CI |
2023 | Stallergenes Greer Ltd Initiates European Paediatric Phase III Study with Staloral Birch | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Amer Jaber
COO | Chief Operating Officer | - | 31/12/18 |
Daniel Smith
CTO | Chief Tech/Sci/R&D Officer | - | 10/04/16 |
Nicola Lamacchia
BRD | Director/Board Member | - | 28/02/17 |
Nunzio Antonelli
BRD | Director/Board Member | - | 09/11/15 |
Valerie Benhamou
SEC | Corporate Secretary | - | 15/05/19 |
Jérôme Tilly
HRO | Human Resources Officer | - | 31/12/13 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Nunzio Antonelli
BRD | Director/Board Member | - | 09/11/15 |
Nicola Lamacchia
BRD | Director/Board Member | - | 28/02/17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 19,728,000 | 0 | 0 | - |
Company contact information
Stallergenes Greer Ltd.
Tower Bridge House St Katharine's Way
E1W 1DD, London
+
http://www.stallergenesgreer.comGroup companies
Name | Category and Sector |
---|---|
Stallergenes SAS
|
Sector
1st Jan change | Capi. | |
---|---|---|
+29.68% | 0 | |
+14.68% | 77.46B | |
+13.86% | 8.94B | |
-24.30% | 4.28B | |
+12.79% | 4.18B | |
+31.45% | 4.11B | |
+8.95% | 2.23B | |
-30.57% | 2.06B | |
+8.99% | 1.97B | |
-45.76% | 1.69B |
- Stock Market
- Equities
- STAGR Stock
- Company Stallergenes Greer